Free Trial

Coherus Oncology (CHRS) SEC Filings & 10K Form

Coherus Oncology logo
$0.87 0.00 (-0.25%)
As of 11:42 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Coherus Oncology SEC Filings

DateFilerForm TypeView
07/03/2025
3:10 PM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
5:48 PM
Coherus Oncology (Issuer)
Erbez Georgia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
5:48 PM
Coherus Oncology (Issuer)
Karachun Rita A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
5:49 PM
Coherus Oncology (Issuer)
Ryan Michael Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
5:49 PM
Coherus Oncology (Issuer)
Wahlstrom Mats (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
5:50 PM
Coherus Oncology (Issuer)
Newcomer Lee Nisley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
5:50 PM
Coherus Oncology (Issuer)
O'Donnell-Tormey Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
5:46 PM
Coherus Oncology (Issuer)
Satvat Ali J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
5:47 PM
Coherus Oncology (Issuer)
Newton Charles W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
4:12 PM
Coherus Oncology (Issuer)
Wahlstrom Mats (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
4:58 PM
Coherus Oncology (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
4:59 PM
Coherus Oncology (Issuer)
McMichael Bryan J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2025
4:07 PM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2025
4:37 PM
Coherus Oncology (Subject)
SATTERFIELD THOMAS A JR (Filed by)
Form SCHEDULE 13G
04/14/2025
7:00 AM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
3:28 PM
Coherus Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2025
5:02 AM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
3:31 PM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
7:34 AM
Coherus Oncology (Filer)
Form DEFA14A
03/04/2025
7:32 AM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2025
4:24 PM
Coherus Oncology (Filer)
Form DEFM14A
01/22/2025
6:48 PM
Coherus Oncology (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
6:49 PM
Coherus Oncology (Issuer)
Reider Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
6:51 PM
Coherus Oncology (Issuer)
McMichael Bryan J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
4:21 PM
Coherus Oncology (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:06 PM
Coherus Oncology (Filer)
Form PREM14A
01/13/2025
7:45 PM
Coherus Oncology (Filer)
Form DEFA14A
01/13/2025
3:25 PM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
7:50 PM
Coherus Oncology (Issuer)
Reider Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:51 PM
Coherus Oncology (Issuer)
McMichael Bryan J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:52 PM
Coherus Oncology (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:44 PM
Coherus Oncology (Issuer)
Reider Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:21 PM
Coherus Oncology (Filer)
Form DEFA14A
12/03/2024
6:11 AM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
6:13 AM
Coherus Oncology (Filer)
Form DEFA14A
11/13/2024
3:30 PM
Coherus Oncology (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G
11/06/2024
3:23 PM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
4:15 PM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:39 PM
Coherus Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
3:47 PM
Coherus Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2024
3:23 PM
Coherus Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Which Gold Miner Trades at 30% of NAV? The One Buffett Wants (Ad)

Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside.

Get the name of Buffett’s likely gold target here
07/24/2024
7:14 PM
Coherus Oncology (Issuer)
Reider Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
7:16 PM
Coherus Oncology (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
7:23 AM
Coherus Oncology (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CHRS) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners